不孕症随机对照试验是否浪费了统计功效?试验者应针对预设的预后协变量进行统计校正以提高检验效能
不孕症随机对照试验常因样本量过小无法检测出真实治疗效应,而大型观察性研究因非随机分配无法区分治疗效应与混杂因素。作者提出在统计分析中校正预设的预后协变量可提高检验效能,若采用分层随机化或最小化法,则必须校正才能得到正确结果。文中展示数据表明这一简单、免费且常必要的策略很少被使用,即使在顶级期刊发表的试验中也是如此。
要点
- 不孕症随机对照试验常因样本量过小无法检测出真实治疗效应。
- 统计分析中校正预设的预后协变量可提高检验效能。
- 采用分层随机化或最小化法时,必须校正协变量才能得到正确结果。
核心结论
- 校正协变量不能直接解决试验检验效能不足的问题,但有必要使用合理的方法学以最大化每个试验所提供的信息。
研究设计与样本
- 本文为方法学教学讨论,并提供一个工作示例,未报告具体样本量。
主要发现
- 数据显示,即使在顶级期刊发表的试验中,校正预设预后协变量这一简单、免费且常必要的提高检验效能策略也很少被使用。
关键数值与推荐
- 在不孕症随机对照试验的统计分析中,应校正预设的预后协变量以提高检验效能。
- 若采用了分层随机化或最小化法,则必须进行校正才能得到正确结果。
临床怎么用
- 作者建议在随机对照试验的统计分析中校正预设的预后协变量以提高检验效能。
- 作者指出若采用分层随机化或最小化法,则必须校正协变量才能得到正确结果。
局限性
- 校正协变量不能直接解决试验检验效能不足的问题。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Infertility randomized controlled trials (RCTs) are often too small to detect realistic treatment effects. Large observational studies have been proposed as a solution. However, this strategy threatens to weaken the evidence base further, because non-random assignment to treatments makes it impossible to distinguish effects of treatment from confounding factors. Alternative solutions are required. Power in an RCT can be increased by adjusting for prespecified, prognostic covariates when performing statistical analysis, and if stratified randomization or minimization has been used, it is essential to adjust in order to get the correct answer. We present data showing that this simple, free and frequently necessary strategy for increasing power is seldom employed, even in trials appearing in leading journals. We use this article to motivate a pedagogical discussion and provide a worked example. While covariate adjustment cannot solve the problem of underpowered trials outright, there is an imperative to use sound methodology to maximize the information each trial yields.
引用
- Wilkinson J, Showell M, Taxiarchi VP, et al. Are we leaving money on the table in infertility RCTs? Trialists should statistically adjust for prespecified, prognostic covariates to increase power. Hum Reprod. 2022. PMID: 35199145. doi:10.1093/humrep/deac030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。